Concepedia

Publication | Open Access

Biweekly Gemcitabine/Nab-Paclitaxel as First-line Treatment for Advanced Pancreatic Cancer

DOIFull Paper Access

15

Citations

19

References

2018

Year

Stefania Kokkali, Elli-Sophia Tripodaki, Maria Drizou, Dimitra Stefanou, Elpida Magou, Dimosthenis Zylis, Matthaios Kapiris, Despoina Nasi, C. Georganta, Alexandros Ardavanis
In Vivo

Abstract

Biweekly gemcitabine/nab-paclitaxel seems to have a similar safety and efficacy profile as the original regimen.

References

YearCitations

Page 1